STOCKWATCH
·
Pharmaceuticals
New Launch20 Jun 2025, 12:24 pm

Sai Life Sciences Ltd Commences Commercial Operation of Second Phase of Production Block at Bidar Facility with 91 kL Capacity

AI Summary

Sai Life Sciences Ltd has successfully commenced commercial operation of the second phase of the production block with 91 kL of capacity at its facility in Bidar, Karnataka, India. This is the second and final phase of the overall capacity addition of 195 kL which was under construction at Unit IV Bidar Facility. The combined capacity of Unit IV Bidar Facility will now be 640 kL, equipped to supply Registered Starting Materials (RSM), intermediates, and Active Pharmaceutical Ingredients (APIs) for both clinical and commercial purposes.

Key Highlights

  • Sai Life Sciences Ltd commences commercial operation of the second phase of the production block at its Bidar Facility
  • The second phase has a capacity of 91 kL
  • This is the final phase of a 195 kL capacity addition at the Bidar Facility
  • The combined capacity of the Bidar Facility is now 640 kL
  • The facility is equipped to supply RSM, intermediates, and APIs for both clinical and commercial purposes
SAILIFE
Pharmaceuticals
Sai Life Sciences Ltd

Price Impact